BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35983409)

  • 1. Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction.
    Zhu S; Wu T; Ji Z; Wu Z; Lin H; Shen C; Yang Y; Zheng Q; Hu H
    Dis Markers; 2022; 2022():3780391. PubMed ID: 35983409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
    Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
    Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
    Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
    Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
    He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.
    Song J; Song F; Liu K; Zhang W; Luo R; Tang Y; Ran L
    Aging (Albany NY); 2019 Nov; 11(22):10316-10337. PubMed ID: 31743108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
    Zhong W; Zhang F; Huang C; Lin Y; Huang J
    Front Oncol; 2020; 10():591254. PubMed ID: 33324563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma.
    Zhang YP; Cheng YB; Li S; Zhao N; Zhu ZH
    Bioengineered; 2021 Dec; 12(1):555-564. PubMed ID: 33517850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of candidate biomarker
    Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
    [No Abstract]   [Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma.
    Mlcochova H; Machackova T; Rabien A; Radova L; Fabian P; Iliev R; Slaba K; Poprach A; Kilic E; Stanik M; Redova-Lojova M; Svoboda M; Dolezel J; Vyzula R; Jung K; Slaby O
    Sci Rep; 2016 Aug; 6():31852. PubMed ID: 27549611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.